Fatemeh Aghai

Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma

Fatemeh Aghai, Sebastian Zimmermann, Max Kurlbaum et al. · Analytical and Bioanalytical Chemistry · 2020 · 37 citations · Full text

Volumetric absorptive microsampling (VAMS) for the quantification of ten kinase inhibitors and determination of their in vitro VAMS-to-plasma ratio

Sebastian Zimmermann, Fatemeh Aghai, Bastian Schilling et al. · Journal of Pharmaceutical and Biomedical Analysis · 2022 · 27 citations

Volumetric Absorptive Microsampling, Vitro Vams-to-plasma Ratio, Pharmaceutical Science +14

Ruxolitinib exposure in patients with acute and chronic graft versus host disease in routine clinical practice—a prospective single-center trial

Nora Isberner, Sabrina Kraus, Götz Ulrich Grigoleit et al. · Cancer Chemotherapy and Pharmacology · 2021 · 16 citations · Full text

Clinical validation and assessment of feasibility of volumetric absorptive microsampling (VAMS) for monitoring of nilotinib, cabozantinib, dabrafenib, trametinib, and ruxolitinib

Sebastian Zimmermann, Fatemeh Aghai, Sabrina Kraus et al. · Journal of Pharmaceutical and Biomedical Analysis · 2023 · 14 citations

Volumetric Absorptive Microsampling, Therapeutic Drug Monitoring, Medicine +7

A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug–Drug Interaction Frequently Observed in Graft versus Host Disease Patients

Bettina Gerner, Fatemeh Aghai, Sabrina Kraus et al. · Pharmaceutics · 2022 · 12 citations · Full text